Cargando…

Differential Proteomic Analysis of Nuclear Matrix in Muscle-Invasive Bladder Cancer: Potential to Improve Diagnosis and Prognosis

Introduction: Although several molecular markers for bladder cancer have been identified, at present little information on prognostic biomarkers is available in the literature. Prognostication of this tumor is largely based on clinicopathological characteristics. Our aim was to identify nuclear matr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barboro, Paola, Rubagotti, Alessandra, Orecchia, Paola, Spina, Bruno, Truini, Mauro, Repaci, Erica, Carmignani, Giorgio, Romagnoli, Andrea, Introini, Carlo, Boccardo, Francesco, Carnemolla, Barbara, Balbi, Cecilia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2008
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618805/ https://www.ncbi.nlm.nih.gov/pubmed/18219107 http://dx.doi.org/10.1155/2008/686940

Ejemplares similares

Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer
por: Barboro, P, et al.
Publicado: (2009)

The Role of Nuclear Matrix Proteins Binding to Matrix Attachment Regions (MARs) in Prostate Cancer Cell Differentiation
por: Barboro, Paola, et al.
Publicado: (2012)

Androgen Receptor Activity Is Affected by Both Nuclear Matrix Localization and the Phosphorylation Status of the Heterogeneous Nuclear Ribonucleoprotein K in Anti-Androgen-Treated LNCaP Cells
por: Barboro, Paola, et al.
Publicado: (2013)

Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer
por: Cattrini, Carlo, et al.
Publicado: (2020)

Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients
por: Cattrini, Carlo, et al.
Publicado: (2019)

Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer
por: Cattrini, Carlo, et al.
Publicado: (2020)

Proteomics study of silver nanoparticles on Caco-2 cells
por: Gioria, Sabrina, et al.
Publicado: (2018)

A combined proteomics and metabolomics approach to assess the effects of gold nanoparticles in vitro
por: Gioria, Sabrina, et al.
Publicado: (2016)

Schedule-dependent therapeutic efficacy of L19mTNF-α and melphalan combined with gemcitabine
por: Mortara, Lorenzo, et al.
Publicado: (2013)

Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy
por: Mortara, Lorenzo, et al.
Publicado: (2018)

Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts
por: Orecchia, Paola, et al.
Publicado: (2015)

Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
por: Ferrari, Nicoletta, et al.
Publicado: (2017)

The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcome
por: Nuzzo, P. V., et al.
Publicado: (2016)

A hnRNP K–AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer
por: Capaia, Matteo, et al.
Publicado: (2018)

L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model
por: Orecchia, Paola, et al.
Publicado: (2019)

Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death
por: Nuzzo, Pier Vitale, et al.
Publicado: (2012)

Prognostic Value of Preoperative Serum Levels of Periostin (PN) in Early Breast Cancer (BCa)
por: Nuzzo, Pier Vitale, et al.
Publicado: (2015)

Cytoskeleton and nuclear lamina affection in recessive osteogenesis imperfecta: A functional proteomics perspective
por: Gagliardi, Assunta, et al.
Publicado: (2017)

The diagnostic and prognostic value of nuclear matrix protein 22 in bladder cancer
por: Tang, Xingxing, et al.
Publicado: (2020)

Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer
por: Cattrini, Carlo, et al.
Publicado: (2019)

Unveiling the Trypanosoma cruzi Nuclear Proteome
por: dos Santos Júnior, Agenor de Castro Moreira, et al.
Publicado: (2015)

Screening for urinary bladder cancer with the use of nuclear matrix protein (NMP) 22: is it feasible?
por: Stefanopoulos, Anastasios, et al.
Publicado: (2014)

The Nuclear Envelope and the Nuclear Matrix
por: Berg, Celeste A.
Publicado: (1982)

Proteomics: Back to the future
por: Roncada, Paola, et al.
Publicado: (2016)

Nuclear Matrix Protein 22 in Voided Urine Cytology Efficacy in Risk Stratification for Carcinoma of Bladder
por: Sankhwar, Monica, et al.
Publicado: (2013)

The Diagnostic Value of Nuclear Matrix Proteins in Bladder Cancer in the Aspect of Environmental Risk from Carcinogens
por: Szymańska, Beata, et al.
Publicado: (2017)

Bladder Cancer–Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasive Bladder Cancer Detection
por: Wang, Zhi-Yong, et al.
Publicado: (2018)

Centripetal nuclear shape fluctuations associate with chromatin condensation in early prophase
por: Introini, Viola, et al.
Publicado: (2023)

Use of the Nuclear Matrix Protein 22 BladderChek Test for the Detection of Primary and Recurrent Urothelial Carcinoma
por: Xia, Chang-sheng, et al.
Publicado: (2020)

Diagnostic performance of nuclear matrix protein 22 and urine cytology for bladder cancer: A meta‐analysis
por: Wang, Jie, et al.
Publicado: (2022)

Comment on “Bladder Cancer–Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasive Bladder Cancer Detection”
por: Güllü Amuran, Gökçe
Publicado: (2019)

Proteome-level display by 2-dimensional chromatography of extracellular matrix-dependent modulation of the phenotype of bladder cancer cells
por: Hurst, Robert E, et al.
Publicado: (2006)

Untargeted lipidomics reveal association of elevated plasma C18 ceramide levels with reduced survival in metastatic castration-resistant prostate cancer patients
por: Cattrini, Carlo, et al.
Publicado: (2023)

Sorting the nuclear proteome
por: Bauer, Denis C., et al.
Publicado: (2011)

The seed nuclear proteome
por: Repetto, Ombretta, et al.
Publicado: (2012)

Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseases
por: Herbster, Suellen, et al.
Publicado: (2018)

Retraction Notice to: Nuclear Matrix Protein 22 in Voided Urine Cytology Efficacy in Risk Stratification for Carcinoma of Bladder
Publicado: (2022)

Tools for Assessing Neuropathic Pain
por: Cruccu, Giorgio, et al.
Publicado: (2009)

Neuropathic Pain: The Scope of the Problem
por: Cruccu, Giorgio, et al.
Publicado: (2017)

A review of Neuropathic Pain: From Guidelines to Clinical Practice
por: Cruccu, Giorgio, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sahvv7fbjb4f418oqspj1i94g2